Key Takeaways:
Inside a one-week interval, there have been two actions on the federal stage to extend pharmacy advantages supervisor (PBM) transparency. The Consolidated Appropriations Act of 2026 (CAA 2026) and Division of Labor (DOL) proposed laws on PBM compensation disclosures (DOL Proposed Guidelines) are complementary however differ in important respects. CAA 2026 is broader in scope (making use of to all group well being plans, together with absolutely insured preparations), however has a later efficient date and creates distinctions based mostly on employer/plan dimension. In distinction, the DOL Proposed Guidelines solely cowl compensation disclosures and apply solely to self-funded ERISA plans however would take impact a lot sooner and apply uniformly no matter employer dimension.
From a compliance perspective, CAA 2026’s categorical civil penalties ($10,000 per day for non-disclosure; $100,000 per merchandise for false info) present a extra direct enforcement mechanism, whereas the DOL Proposed Guidelines leverage the ERISA prohibited transaction framework, which can lead to excise taxes and equitable cures however lacks the identical bright-line penalty construction.
Notably, CAA 2026 mandates 100% rebate pass-through for plans topic to ERISA, whereas the DOL Proposed Guidelines require solely disclosure of rebates retained versus handed by — a key distinction for plan sponsors and business actors.
Potential for DOL Regulatory Revisions:
Given the near-simultaneous issuance of CAA 2026 and the DOL Proposed Guidelines, there’s important potential for the DOL to revise its ultimate rule to align with the statutory necessities enacted in CAA 2026. The DOL Proposed Guidelines had been developed pursuant to Government Order 14273 and construct upon the present ERISA Part 408(b)(2) framework, however the proposal was finalized earlier than the DOL may absolutely account for the excellent PBM transparency and rebate pass-through necessities that Congress subsequently enacted in CAA 2026. Consequently, the DOL will probably must harmonize its disclosure necessities, timing provisions, and employer-size distinctions with these mandated by statute to keep away from duplicative or conflicting obligations for plan sponsors, PBMs, and different coated entities.
Plan sponsors and PBMs ought to anticipate that the DOL’s ultimate rule (anticipated after the remark deadline) could also be considerably revised to coordinate with CAA 2026’s necessities. Specifically, the DOL might must rethink its proposed July 1, 2026 applicability date, provided that CAA 2026 doesn’t take impact till January 1, 2029 for calendar-year plans, creating a possible hole interval throughout which the DOL’s extra restricted disclosure necessities would apply to self-insured ERISA plans earlier than the broader CAA 2026 mandates take impact — together with 100% rebate pass-through for ERISA plans. Stakeholders ought to monitor the DOL’s response to public feedback and any coordination efforts between the DOL and different federal businesses (together with the U.S. Division of Well being and Human Companies) to make sure a unified regulatory strategy to PBM oversight.
Comparability Desk
The desk beneath compares key parts of CAA 2026 and the DOL Proposed Guidelines.
| Class | CAA 2026 | DOL Proposed Guidelines |
| Efficient Date |
January 1, 2029, for calendar 12 months plans. [Plan years beginning 30 months after enactment]. |
January 1, 2027, for calendar 12 months plans. [Effective 60 calendar days after publication of the final rule; applicable to plan years beginning on or after July 1, 2026]. |
| Applicability |
Disclosure necessities apply on to: (1) group well being plans, (2) medical insurance issuers providing group medical insurance protection, and (3) entities offering pharmacy profit administration providers on behalf of such plans or issuers. Oblique software to “relevant entities” together with drug producers, distributors, wholesalers, rebate aggregators, relevant group buying organizations, and their subsidiaries, associates, or subcontractors. Rebate pass-through necessities apply to entities offering pharmacy profit administration providers for ERISA plans (ropes in carriers, Third-Social gathering Directors (TPAs), rebate aggregators, and others). |
Direct software to self-funded ERISA group well being plans. Oblique software to “coated service suppliers” that contract with self-insured group well being plans to supply pharmacy profit administration providers.
|
| Employer Measurement Distinction |
Giant employers (100+ workers) and huge plans (100+ contributors) obtain detailed drug-level PBM stories with contracted compensation, rebates, unfold, and pricing knowledge. Smaller employers/plans obtain a extra restricted abstract doc with combination info. |
Apply to all self-insured ERISA plans no matter employer dimension.
|
| Plans Lined | Group well being plans (each absolutely insured and self-funded) and medical insurance issuers beneath ERISA, the Inner Income Code, and the Public Well being Service Act. |
Self-insured ERISA group well being plans solely. Totally insured group well being plans are explicitly excluded (reserved for future motion). |
| Civil Penalties |
Specific civil financial penalties:
|
Enforcement is thru ERISA’s prohibited transaction framework beneath §408(b)(2).
|
| Reporting Frequency | Semiannual stories (or quarterly at plan’s request). | Preliminary disclosures earlier than getting into/renewing contracts, semiannual disclosures (inside 30 days after every six-month interval), and disclosures of data for employer reporting upon request. |
| Info to be Disclosed |
Detailed drug-level knowledge for big employers/plans together with:
|
Comparable disclosure classes together with:
|
| Rebate Cross-Via Requirement |
100% rebate pass-through required for ERISA plans solely.
|
No rebate pass-through mandate; disclosure solely.
|
| Audit Rights |
Annual rebate audit rights required for ERISA plans solely.
|
Annual audit rights required.
|
| Fiduciary Reduction/Secure Harbor | Harmless plan fiduciary exemption for failures attributable to PBMs, offered fiduciary didn’t know and fairly believed compliance occurred. |
Administrative class exemption for accountable plan fiduciaries if PBM fails to conform, offered fiduciary:
|
| Authorized Authority | Enacted by statutory modification to the Public Well being Service Act, ERISA, and Inner Income Code. | Administrative regulation beneath ERISA §408(b)(2)(A), §408(b)(2)(B), and §505. |
The put up PBM Reform Cheat Sheet: Chart Evaluating the Current Guidelines for Group Plans appeared first on Foley & Lardner LLP.